info@targetmol.com    Tel: (857) 239-0968 / (617) 419-7131
Home > PARP
PARP
Cat.No. Product Name Information Area
T3917 Protopanaxatriol Protopanaxatriol, a major ginseng constituent, is a novel PPARγ antagonist.The inhibi... Metabolism system
T3231 Niraparib MK-4827(Niraparib) is a selective inhibitor of PARP1/PARP2 with IC50 of 3.8 nM/2.1 nM... Others
T3157 COH29 COH29 is an orally available, aromatically substituted thiazole and inhibitor of the ... Cancer
T3649 BGP-15 BGP-15 is a?PARP?inhibitor which has protective effect after schemia reperfusion inju... Metabolism
T6942 Picolinamide Picolinamide is found to be a strong inhibitor of poly (ADP-ribose) synthetase of nuc... Others
T6912 NU1025 NU1025 is a potent PARP inhibitor with IC50 of 400 nM. Others
T6892 MK-4827(Niraparib) tosylate MK-4827(Niraparib) tosylate is a selective inhibitor of PARP1/PARP2 with IC50 of 3.8 ... Others
T6842 G007-LK G007-LK is a potent and selective tankyrase inhibitor with IC50 of 46 nM and 25 nM fo... Others
T6780 Benzamide Benzamide, an inhibitor of poly(ADP-ribose) polymerase, is a derivative of benzoic ac... Others
T3375 Verbascosidenew Verbascoside has an antimicrobial activity, notably against Staphylococcus aureus. It... Others
T3261 NVP-TNKS656 NVP-TNKS656(TNKS-656) is a highly potent, selective, and orally active TNKS2 inhibito... Other
T3197 Daprodustat Daprodustat (GSK1278863) is a HIF-prolyl hydroxylase inhibitor. Other
T3180 JNJ-42041935 JNJ-42041935 is a potent (pKi = 7.3-7.9), 2-oxoglutarate competitive, reversible, and... Other
T3170 Troglitazone Troglitazone(CS-045), PPARγ agonist, is an anti-diabetic thiazolidinedione (TZD) with... Cancer
T3168 MN-64 MN-64 is a inhibitor of tankyrases, showed 6 nM potency against tankyrase 1, isoenzym... Cancer
T1264 Ciprofibrate Ciprofibrate is a peroxisome proliferator-activated receptor agonist. It was reported... Cardiovascular system
T6578 ME0328 ME0328 is a potent and selective PARP inhibitor with IC50 of 0.89 μM for PARP3, about... Cancer
T6366 A-966492 A-966492 is a novel and potent inhibitor of PARP1 and PARP2 with Ki of 1 nM and 1.5 n... Cancer
T6253 Talazoparib (BMN 673) Talazoparib (BMN 673) is a novel PARP inhibitor with IC50 of 0.58 nM. It is also a po... Cancer
T6224 Iniparib (BSI-201) Iniparib (BSI-201) is a PARP1 inhibitor with demonstrated effectiveness in triple-neg... Cancer
T6197 PJ34 PJ34 HCl is the hydrochloride salt of PJ34, which is a PARP inhibitor with EC50 of 20... Cancer
T6181 UPF 1069 UPF 1069 is a selective PARP2 inhibitor with IC50 of 0.3 μM. It is ~27-fold selective... Cancer
T6127 Rucaparib (AG-014699,PF-01367338) Rucaparib (AG-014699, PF-01367338) is an inhibitor of PARP with Ki of 1.4 nM for PARP... Cancer
T3015 Olaparibhot Olaparib (AZD2281, KU0059436) is a potent PARP inhibitor with IC50 of 5 and 1 nM for ... Cancer
T2591 Veliparib (ABT-888) Veliparib (ABT-888) is a potent inhibitor of PARP1 and PARP2 with Ki of 5.2 nM and 2.... Cancer
T2484 AZD2461 AZD2461 is a novel PARP inhibitor with low affinity for Pgp than Olaparib. Phase 1. Cancer
T2124 PJ34 hydrochloride PJ34 hydrochloride is the hydrochloride salt of PJ34, which is a PARP inhibitor with ... Other
T2105 Veliparib dihydrochloride Veliparib (ABT-888) is a potent inhibitor of PARP1 and PARP2 with Ki of 5.2 nM and 2.... Other
T1807 JW55 JW 55 is an inhibitor of the PARP domain of tankyrase 1 and 2 (TNKS1/2). JW55 decreas... Other
T6339 AG-14361 AG14361 is a potent inhibitor of PARP1 with Ki of <5 nM. It is at least 1000-fold mor... Cancer
1